144 related articles for article (PubMed ID: 27718458)
1. Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer.
Adamowicz K; Saad ED; Jassem J
Cancer Treat Rev; 2016 Nov; 50():194-199. PubMed ID: 27718458
[TBL] [Abstract][Full Text] [Related]
2. Assessment of quality of life in advanced breast cancer. An overview of randomized phase III trials.
Adamowicz K; Jassem J; Katz A; Saad ED
Cancer Treat Rev; 2012 Aug; 38(5):554-8. PubMed ID: 21807465
[TBL] [Abstract][Full Text] [Related]
3. Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials.
Saad ED; Adamowicz K; Katz A; Jassem J
Cancer Treat Rev; 2012 Oct; 38(6):807-14. PubMed ID: 22445316
[TBL] [Abstract][Full Text] [Related]
4. Assessment of quality of life in phase III trials of radiotherapy in localized or locally advanced head and neck cancer over the past 17 years.
Marta GN; Saad ED
Ann Palliat Med; 2017 Jan; 6(1):73-80. PubMed ID: 28209070
[TBL] [Abstract][Full Text] [Related]
5. Assessment of quality of life in advanced, metastatic prostate cancer: an overview of randomized phase III trials.
Adamowicz K
Qual Life Res; 2017 Apr; 26(4):813-822. PubMed ID: 27738867
[TBL] [Abstract][Full Text] [Related]
6. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
Fiteni F; Anota A; Westeel V; Bonnetain F
BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer.
Byrne C; Griffin A; Blazeby J; Conroy T; Efficace F
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S95-104. PubMed ID: 18039559
[TBL] [Abstract][Full Text] [Related]
8. Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: A review of randomized controlled clinical trials.
de Kort SJ; Willemse PH; Habraken JM; de Haes HC; Willems DL; Richel DJ
Eur J Cancer; 2006 May; 42(7):835-45. PubMed ID: 16481158
[TBL] [Abstract][Full Text] [Related]
9. Associations between safety, tolerability, and toxicity and the reporting of health-related quality of life in phase III randomized trials in common solid tumors.
Saleh RR; Meti N; Ribnikar D; Goldvaser H; Ocana A; Templeton AJ; Seruga B; Amir E
Cancer Med; 2020 Nov; 9(21):7888-7895. PubMed ID: 32886422
[TBL] [Abstract][Full Text] [Related]
10. A critical evaluation of quality of life in clinical trials of breast cancer patients treated with radiation therapy.
Marta GN; Moraes FY; Leite ETT; Chow E; Cella D; Bottomley A
Ann Palliat Med; 2017 Dec; 6(Suppl 2):S223-S232. PubMed ID: 29156916
[TBL] [Abstract][Full Text] [Related]
11. [Health-related quality of life in phase III cancer clinical trials: from questionnaire administration to statistical analysis].
Fiteni F; Anota A; Westeel V; Bonnetain F
Bull Cancer; 2015 Apr; 102(4):360-6. PubMed ID: 25799875
[TBL] [Abstract][Full Text] [Related]
12. Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018.
Lombardi P; Marandino L; De Luca E; Zichi C; Reale ML; Pignataro D; Di Stefano RF; Ghisoni E; Mariniello A; Trevisi E; Leone G; Muratori L; La Salvia A; Sonetto C; Leone F; Aglietta M; Novello S; Scagliotti GV; Perrone F; Di Maio M
Crit Rev Oncol Hematol; 2020 Feb; 146():102877. PubMed ID: 31981880
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.
Fiteni F; Ray IL; Ousmen A; Isambert N; Anota A; Bonnetain F
BMC Cancer; 2019 Apr; 19(1):361. PubMed ID: 30991990
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in patients undergoing drug therapy for advanced non-small-cell lung cancer.
Fallowfield LJ; Harper P
Lung Cancer; 2005 Jun; 48(3):365-77. PubMed ID: 15893006
[TBL] [Abstract][Full Text] [Related]
15. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.
Au HJ; Ringash J; Brundage M; Palmer M; Richardson H; Meyer RM;
Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):119-28. PubMed ID: 20384559
[TBL] [Abstract][Full Text] [Related]
16. [Trans-sectoral care for patients with colorectal cancer: Design of a prospective randomized controlled multi-center trial (FKZ 01GY1143)].
Landenberger M; Boese S; Fach EM; Bauer A
Z Evid Fortbild Qual Gesundhwes; 2015; 109(2):171-80. PubMed ID: 26028456
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
Kabbinavar FF; Wallace JF; Holmgren E; Yi J; Cella D; Yost KJ; Hurwitz HI
Oncologist; 2008 Sep; 13(9):1021-9. PubMed ID: 18776057
[TBL] [Abstract][Full Text] [Related]
18. Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials.
Efficace F; Bottomley A; Vanvoorden V; Blazeby JM
Eur J Cancer; 2004 Jan; 40(2):187-97. PubMed ID: 14728932
[TBL] [Abstract][Full Text] [Related]
19. Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review.
Ter Veer E; van Kleef JJ; Sprangers MAG; Haj Mohammad N; van Oijen MGH; van Laarhoven HWM
Gastric Cancer; 2018 Mar; 21(2):183-195. PubMed ID: 29380191
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in colorectal cancer.
Färkkilä N; Sintonen H; Saarto T; Järvinen H; Hänninen J; Taari K; Roine RP
Colorectal Dis; 2013 May; 15(5):e215-22. PubMed ID: 23351057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
